The Influence of Drug-Polymer Solubility on Laser-Induced In Situ Drug Amorphization Using Photothermal Plasmonic Nanoparticles

In this study, laser-induced in situ amorphization (i.e., amorphization inside the final dosage form) of the model drug celecoxib (CCX) with six different polymers was investigated. The drug-polymer combinations were studied with regard to the influence of (i) the physicochemical properties of the p...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Nele-Johanna Hempel (Author), Padryk Merkl (Author), Matthias Manne Knopp (Author), Ragna Berthelsen (Author), Alexandra Teleki (Author), Georgios A. Sotiriou (Author), Korbinian Löbmann (Author)
Formato: Livro
Publicado em: MDPI AG, 2021-06-01T00:00:00Z.
Assuntos:
Acesso em linha:Connect to this object online.
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_44615c36a38d4452ac95afc63d8664d0
042 |a dc 
100 1 0 |a Nele-Johanna Hempel  |e author 
700 1 0 |a Padryk Merkl  |e author 
700 1 0 |a Matthias Manne Knopp  |e author 
700 1 0 |a Ragna Berthelsen  |e author 
700 1 0 |a Alexandra Teleki  |e author 
700 1 0 |a Georgios A. Sotiriou  |e author 
700 1 0 |a Korbinian Löbmann  |e author 
245 0 0 |a The Influence of Drug-Polymer Solubility on Laser-Induced In Situ Drug Amorphization Using Photothermal Plasmonic Nanoparticles 
260 |b MDPI AG,   |c 2021-06-01T00:00:00Z. 
500 |a 10.3390/pharmaceutics13060917 
500 |a 1999-4923 
520 |a In this study, laser-induced in situ amorphization (i.e., amorphization inside the final dosage form) of the model drug celecoxib (CCX) with six different polymers was investigated. The drug-polymer combinations were studied with regard to the influence of (i) the physicochemical properties of the polymer, e.g., the glass transition temperature (<i>T</i><sub>g</sub>) and (ii) the drug-polymer solubility on the rate and degree of in situ drug amorphization. Compacts were prepared containing 30 wt% CCX, 69.25 wt% polymer, 0.5 wt% lubricant, and 0.25 wt% plasmonic nanoparticles (PNs) and exposed to near-infrared laser radiation. Upon exposure to laser radiation, the PNs generated heat, which allowed drug dissolution into the polymer at temperatures above its <i>T</i><sub>g</sub>, yielding an amorphous solid dispersion. It was found that in situ drug amorphization was possible for drug-polymer combinations, where the temperature reached during exposure to laser radiation was above the onset temperature for a dissolution process of the drug into the polymer, i.e., <i>T</i><sub>DStart</sub>. The findings of this study showed that the concept of laser-induced in situ drug amorphization is applicable to a range of polymers if the drug is soluble in the polymer and temperatures during the process are above <i>T</i><sub>DStart</sub>. 
546 |a EN 
690 |a oral drug delivery 
690 |a in situ drug amorphization 
690 |a polymers 
690 |a amorphous solid dispersion 
690 |a laser radiation 
690 |a plasmonic nanoparticles 
690 |a Pharmacy and materia medica 
690 |a RS1-441 
655 7 |a article  |2 local 
786 0 |n Pharmaceutics, Vol 13, Iss 6, p 917 (2021) 
787 0 |n https://www.mdpi.com/1999-4923/13/6/917 
787 0 |n https://doaj.org/toc/1999-4923 
856 4 1 |u https://doaj.org/article/44615c36a38d4452ac95afc63d8664d0  |z Connect to this object online.